News
Preliminary findings linking RSV and shingles vaccines to lower dementia risk are intriguing but not conclusive, local ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
2d
HealthDay on MSNCDC Now Recommends RSV Vaccine for Some Adults Aged 50 Years and OlderThe CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
Two new studies demonstrate the impact of respiratory syncytial virus (RSV) in different populations, with one showing that ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
13d
News-Medical.Net on MSNShingles and RSV vaccines with AS01 adjuvant reduce dementia riskResearchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...
11d
Medpage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotThe new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results